---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001196"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2021-10-12T23:59:59+00:00"
generated_at: "2026-06-28T21:40:49.852647+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# USANA appoints Xia Ding to board of directors, effective Oct 11, 2021

## Summary
- Xia Ding appointed as independent director; initial term through 2022 annual meeting.
- Ms. Ding is Vice President of e-commerce Asia Pacific & Latin America at Nike.
- Board expands to eight members, six of whom are independent.
- Ms. Ding has not been assigned to any board committees at this time.
- She brings e-commerce and digital leadership from Nike, JD.com, and Hanesbrands.

## SEC filing metadata
- accession: 0001157523-21-001196
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2021-10-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752321001196/0001157523-21-001196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752321001196/a52507810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001196
- JSON: https://secwatch.observer/filing/0001157523-21-001196.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001196.txt

## Key facts
- Executive change
  Xia Ding was appointed as director at USANA HEALTH SCIENCES INC.
  - Action: appointed
  - Role: director
  source text: Effective as of October 11, 2021, the Board of Directors of USANA Health Sciences, Inc. (the “Company”) acted unanimously to appoint Xia Ding as an additional director of the Company, for an initial term expiring at the Company’s 2022 Annual Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000115752321001196/0001157523-21-001196-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.